OBJECTIVES: This study evaluated whether obesity in humans was associated with an increase in circulating hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels. BACKGROUND: Obesity acts as a cardiovascular risk factor by mechanisms that are not fully understood. Adipose tissue is able to secrete multiple cytokines and growth factors ex vivo. We hypothesized that the increased presence of adipose tissue in obese subjects results in systemic elevations of the mitogenic factors HGF and VEGF. METHODS: Blood samples were obtained from lean (n = 21) and obese (n = 44) volunteers. Serum HGF and VEGF levels were assessed by enzyme-linked immunoadsorbent assay. Insulin and fasting glucose levels were measured to evaluate insulin sensitivity. Conditioned medium of adipose cells was assayed for HGF secretion. RESULTS: Serum HGF levels in obese subjects were more than three-fold higher than those of lean subjects (2,462 +/- 184 pg/ml vs. 765 +/- 48 pg/ml, p < 0.0001). The VEGF levels were not significantly elevated in obese subjects (135 +/- 31 pg/ml vs. 128 +/- 37 pg/ml). The HGF concentrations, but not VEGF concentrations, were significantly correlated with body mass index (BMI) (p < 0.0001, r = 0.74). The observed increases in HGF concentrations of obese subjects were not secondary to insulin resistance or hypertension. Freshly isolated human adipose cells secreted HGF. CONCLUSIONS: Our results indicate that obesity is associated with a marked increase in circulating HGF levels, which correlate linearly with BMI. Because vascular growth factors have been associated with the pathogenesis of atherosclerosis, the possible role of such humoral factors as a link between obesity and cardiovascular disease is very intriguing.
OBJECTIVES: This study evaluated whether obesity in humans was associated with an increase in circulating hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels. BACKGROUND:Obesity acts as a cardiovascular risk factor by mechanisms that are not fully understood. Adipose tissue is able to secrete multiple cytokines and growth factors ex vivo. We hypothesized that the increased presence of adipose tissue in obese subjects results in systemic elevations of the mitogenic factors HGF and VEGF. METHODS: Blood samples were obtained from lean (n = 21) and obese (n = 44) volunteers. Serum HGF and VEGF levels were assessed by enzyme-linked immunoadsorbent assay. Insulin and fasting glucose levels were measured to evaluate insulin sensitivity. Conditioned medium of adipose cells was assayed for HGF secretion. RESULTS: Serum HGF levels in obese subjects were more than three-fold higher than those of lean subjects (2,462 +/- 184 pg/ml vs. 765 +/- 48 pg/ml, p < 0.0001). The VEGF levels were not significantly elevated in obese subjects (135 +/- 31 pg/ml vs. 128 +/- 37 pg/ml). The HGF concentrations, but not VEGF concentrations, were significantly correlated with body mass index (BMI) (p < 0.0001, r = 0.74). The observed increases in HGF concentrations of obese subjects were not secondary to insulin resistance or hypertension. Freshly isolated human adipose cells secreted HGF. CONCLUSIONS: Our results indicate that obesity is associated with a marked increase in circulating HGF levels, which correlate linearly with BMI. Because vascular growth factors have been associated with the pathogenesis of atherosclerosis, the possible role of such humoral factors as a link between obesity and cardiovascular disease is very intriguing.
Authors: José A González-Pertusa; John Dubé; Shelley R Valle; Taylor C Rosa; Karen K Takane; José M Mellado-Gil; Germán Perdomo; Rupangi C Vasavada; Adolfo García-Ocaña Journal: Endocrinology Date: 2010-02-22 Impact factor: 4.736
Authors: Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani Journal: Cancer Date: 2011-07-12 Impact factor: 6.860
Authors: Nicholas B Larson; Cecilia Berardi; Paul A Decker; Christina L Wassel; Phillip S Kirsch; James S Pankow; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Kent D Taylor; Suzette J Bielinski Journal: Ann Hum Genet Date: 2015-05-22 Impact factor: 1.670
Authors: Kristina L Makey; Sharla G Patterson; James Robinson; Mark Loftin; Dwight E Waddell; Lucio Miele; Edmund Chinchar; Min Huang; Andrew D Smith; Mark Weber; Jian-Wei Gu Journal: Eur J Cancer Prev Date: 2013-01 Impact factor: 2.497
Authors: Radosław Wieczór; Anna Maria Wieczór; Grażyna Gadomska; Katarzyna Stankowska; Jacek Fabisiak; Karol Suppan; Grzegorz Pulkowski; Jacek Budzyński; Danuta Rość Journal: J Zhejiang Univ Sci B Date: 2016 Nov. Impact factor: 3.066
Authors: Yian Gu; Anne Zeleniuch-Jacquotte; Faina Linkov; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Adele Marrangoni; Paolo Toniolo; Anna E Lokshin; Alan A Arslan Journal: Cytokine Date: 2008-12-05 Impact factor: 3.861
Authors: Swapnil N Rajpathak; Sylvia Wassertheil-Smoller; Jill Crandall; Simin Liu; Gloria Y F Ho Journal: Diabetes Care Date: 2010-06-02 Impact factor: 19.112
Authors: Yan Zhang; Alexes Daquinag; Dmitry O Traktuev; Felipe Amaya-Manzanares; Paul J Simmons; Keith L March; Renata Pasqualini; Wadih Arap; Mikhail G Kolonin Journal: Cancer Res Date: 2009-06-02 Impact factor: 12.701
Authors: German Perdomo; Maria A Martinez-Brocca; Bankim A Bhatt; Nicholas F Brown; Robert M O'Doherty; Adolfo Garcia-Ocaña Journal: J Biol Chem Date: 2008-03-24 Impact factor: 5.157